Transformative Biotech, LLC

Transformative Biotech is focused on developing innovative diagnostic solutions using direct-to-PCR technology. Their primary goal is to revolutionize molecular testing for infectious diseases and cancer by offering rapid, highly accurate, and cost-effective solutions. Transformative Biotech is developing advanced PCR-based tests for various diseases. Their technology has the potential to rapidly diagnose a wide range of infectious pathogens, including viruses and bacteria. They are also exploring the application of their technology for early detection and monitoring of cancer. Their lead products are SalivaFAST™ and SwabFAST™. These SARS-CoV-2 tests eliminate the need for complex sample preparation, streamlining the testing process and are designed to offer rapid, accurate, and cost-effective alternatives to traditional RT-PCR testing. They have demonstrated comparable accuracy to RT-PCR (CDC assay) in diagnosing SARS-CoV-2 infection.

Jobs: